Belgian biotech Galapagos (Euronext: GLPG) is pausing its high-profile plan to break into two separate businesses, just five ...

Finnish biotech Tilt Biotherapeutics has raised $26 million (22.6 million euros) in a series B round to move its lead cancer ...

Compugen, an Israeli cancer immunotherapy company that calls itself a pioneer in computational target discovery, has ...

The Russian authorities are preparing for a further reduction of the share of imported drugs in the domestic public ...

Belgian clinical-stage biotech iTeos Therapeutics (Nasdaq: ITOS) saw its shar leap18.6% to $8.20 today, despite posting ...

Denmark’s Novo Nordisk has presented data at the European Congress of Obesity (ECO) showing that Wegovy (semaglutide ...

Privately-held Remedy Plan Therapeutics, a US pharma company developing novel, hyperbolic NAMPT inhibitors, has raised more ...

They are the two drugs of the moment, the weight loss products promising a miraculous solution to obesity and—in data ...

Swedish biotech Hansa Biopharma (Nasdaq Stockholm: HNSA) has appointed Maria Törnsén as chief operating officer and president ...

India has declined the UK's request to include a 'data exclusivity' clause in the proposed Free Trade Agreement (FTA), as ...

Swedish contract development and manufacturing firm Recipharm and France-based regulatory specialist ProductLife Group (PLG) ...

US pharma stocks regained ground Monday after Donald Trump signed an executive order aiming to slash prescription drug prices ...